The United States Supreme Court today granted a request by Department of Justice and manufacturers of Mifepristone to stay decisions from the Fifth Circuit Court of Appeals and a Texas federal district court order that severely restricted access to the widely used medication for terminating pregnancy and managing miscarriages. The ruling preserves the status quo regarding medication’s use across the country.
The following can be attributed to Ameri Klafeta, Director of the Women’s and Reproductive Rights Project at the ACLU of Illinois:
This is good news and a great relief to patients and physicians seeking to use medication that has been safe and effective for millions of patients for more than two decades. Both the law and science should dictate Mifepristone’s continued availability for those seeking to terminate a pregnancy and manage miscarriage.
In Illinois, everyone should be clear: Abortion remains safe and legal including medication abortion. We will continue to fight for broad access to abortion care in our state.